Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy.

Sola-Gazagnes A, Faucher P, Jacqueminet S, Ciangura C, Dubois-Laforgue D, Mosnier-Pudar H, Roussel R, Larger E.

Diabetes Metab. 2019 Aug 13. pii: S1262-3636(19)30124-7. doi: 10.1016/j.diabet.2019.08.001. [Epub ahead of print]

PMID:
31415813
2.

Impact of a sports project centered on scuba diving for adolescents with type 1 diabetes mellitus: New guidelines for adolescent recreational diving, a modification of the French regulations.

Lormeau B, Pichat S, Dufaitre L, Chamouine A, Gataa M, Rastami J, Coll-Lormeau C, Goury G, François AL, Etien V, Blanchard JL, Hervé D, Sola-Gazagnes A.

Arch Pediatr. 2019 Apr;26(3):161-167. doi: 10.1016/j.arcped.2018.12.006. Epub 2019 Mar 15.

PMID:
30885605
3.

[Diagnostic circumstances and clinical forms of type 1 diabetes].

Larger É, Diedisheim M, Donath X, Dehghani L, Sola-Gazagnes A.

Rev Prat. 2018 Jun;68(6):614-618. Review. French.

PMID:
30869248
4.

Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.

Borot S, Benhamou PY, Atlan C, Bismuth E, Bonnemaison E, Catargi B, Charpentier G, Farret A, Filhol N, Franc S, Gouet D, Guerci B, Guilhem I, Guillot C, Jeandidier N, Joubert M, Melki V, Merlen E, Penfornis A, Picard S, Renard E, Reznik Y, Riveline JP, Rudoni S, Schaepelynck P, Sola-Gazagnes A, Tubiana-Rufi N, Verier-Mine O, Hanaire H; Société francophone du diabète (SFD), Société française d’endocrinologie (SFE); Évaluation dans le diabète des implants actifs Group (EVADIAC).

Diabetes Metab. 2018 Feb;44(1):61-72. doi: 10.1016/j.diabet.2017.10.009. Epub 2017 Nov 11.

PMID:
29174479
5.

Delay discounting of gains and losses, glycemic control and therapeutic adherence in type 2 diabetes.

Lebeau G, Consoli SM, Le Bouc R, Sola-Gazagnes A, Hartemann A, Simon D, Reach G, Altman JJ, Pessiglione M, Limosin F, Lemogne C.

Behav Processes. 2016 Nov;132:42-48. doi: 10.1016/j.beproc.2016.09.006. Epub 2016 Sep 20.

PMID:
27663668
6.

Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement.

Joubert M, Baillot-Rudoni S, Catargi B, Charpentier G, Esvant A, Franc S, Guerci B, Guilhem I, Melki V, Merlen E, Penfornis A, Renard E, Riveline JP, Schaepelynck P, Sola-Gazagnes A, Hanaire H; Société Francophone du Diabète (SFD); Société Française d’Endocrinologie (SFE); EVAluation dans le Diabète des Implants ACtifs Group (EVADIAC).

Diabetes Metab. 2015 Dec;41(6):498-508. doi: 10.1016/j.diabet.2015.07.001. Epub 2015 Aug 7.

PMID:
26260529
7.

[Treatment of diabetes with an insulin pump].

Defer F, Tourneur ML, Guillaume C, Sola-Gazagnes A.

Rev Infirm. 2015 Jan;(207):49-50. doi: 10.1016/j.revinf.2014.10.023. Epub 2014 Dec 29. French. No abstract available.

PMID:
26144521
8.

Assessment of a new insulin preparation for implanted pumps used in the treatment of type 1 diabetes.

Schaepelynck P, Riveline JP, Renard E, Hanaire H, Guerci B, Baillot-Rudoni S, Sola-Gazagnes A, Catargi B, Fontaine P, Millot L, Martin JF, Tachouaft H, Jeandidier N; EVADIAC Group.

Diabetes Technol Ther. 2014 Sep;16(9):582-9. doi: 10.1089/dia.2013.0369. Epub 2014 Apr 15.

PMID:
24735100
9.

Effect of dietary protein on post-prandial glucose in patients with type 1 diabetes.

Borie-Swinburne C, Sola-Gazagnes A, Gonfroy-Leymarie C, Boillot J, Boitard C, Larger E.

J Hum Nutr Diet. 2013 Dec;26(6):606-11. doi: 10.1111/jhn.12082. Epub 2013 Mar 22.

PMID:
23521532
10.

Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.

Hasselmann C, Pecquet C, Bismuth E, Raverdy C, Sola-Gazagnes A, Lobut JB, Carel JC, Tubiana-Rufi N.

Diabetes Metab. 2013 Apr;39(2):174-7. doi: 10.1016/j.diabet.2012.10.002. Epub 2012 Dec 1.

PMID:
23206896
11.

Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE.

Benhamou PY, Catargi B, Delenne B, Guerci B, Hanaire H, Jeandidier N, Leroy R, Meyer L, Penfornis A, Radermecker RP, Renard E, Baillot-Rudoni S, Riveline JP, Schaepelynck P, Sola-Gazagnes A, Sulmont V, Tubiana-Rufi N, Durain D, Mantovani I, Sola-Gazagnes A, Riveline JP; Société Francophone du Diabète; Société Française d'Endocrinologie; EVAluation dans le Diabète des Implants ACtifs Group.

Diabetes Metab. 2012 Jul;38 Suppl 4:S67-83. doi: 10.1016/S1262-3636(12)71538-0. No abstract available.

12.

The real-time display of data, the miniaturization of current systems and their reliability make possible their long-term use with ambulatory patients.

Sola-Gazagnes A.

Diabetes Metab. 2012 Jul;38 Suppl 4:S65. doi: 10.1016/S1262-3636(12)71537-9. No abstract available.

PMID:
22980519
13.

Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study.

Riveline JP, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A, Penfornis A, Tubiana-Rufi N, Sulmont V, Catargi B, Lukas C, Radermecker RP, Thivolet C, Moreau F, Benhamou PY, Guerci B, Leguerrier AM, Millot L, Sachon C, Charpentier G, Hanaire H; EVADIAC Sensor Study Group.

Diabetes Care. 2012 May;35(5):965-71. doi: 10.2337/dc11-2021. Epub 2012 Mar 28.

14.
15.

Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.

Vigeral C, Sola-Gazagnes A, Nejjar S, M'Bemba J, Boitard C, Slama G, Elgrably F, Larger E.

Diabetes Metab. 2011 Dec;37(6):553-9. doi: 10.1016/j.diabet.2011.06.002. Epub 2011 Jul 28.

PMID:
21802332
16.

Therapeutic alliance and glycaemic control in type 1 diabetes: a pilot study.

Attale C, Lemogne C, Sola-Gazagnes A, Guedeney N, Slama G, Horvath AO, Consoli SM.

Diabetes Metab. 2010 Dec;36(6 Pt 1):499-502. doi: 10.1016/j.diabet.2010.08.003. Epub 2010 Oct 8.

PMID:
20934364
17.

Peak-time determination of post-meal glucose excursions in insulin-treated diabetic patients.

Daenen S, Sola-Gazagnes A, M'Bemba J, Dorange-Breillard C, Defer F, Elgrably F, Larger E, Slama G.

Diabetes Metab. 2010 Apr;36(2):165-9. doi: 10.1016/j.diabet.2009.12.002. Epub 2010 Mar 11.

PMID:
20226708
18.

The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes.

Laloi-Michelin M, Meas T, Ambonville C, Bellanné-Chantelot C, Beaufils S, Massin P, Vialettes B, Gin H, Timsit J, Bauduceau B, Bernard L, Bertin E, Blickle JF, Cahen-Varsaux J, Cailleba A, Casanova S, Cathebras P, Charpentier G, Chedin P, Crea T, Delemer B, Dubois-Laforgue D, Duchemin F, Ducluzeau PH, Bouhanick B, Dusselier L, Gabreau T, Grimaldi A, Guerci B, Jacquin V, Kaloustian E, Larger E, Lecleire-Collet A, Lorenzini F, Louis J, Mausset J, Murat A, Nadler-Fluteau S, Olivier F, Paquis-Flucklinger V, Paris-Bockel D, Raynaud I, Reznik Y, Riveline JP, Schneebeli S, Sonnet E, Sola-Gazagnes A, Thomas JL, Trabulsi B, Virally M, Guillausseau PJ; Mitochondrial Diabetes French Study Group.

J Clin Endocrinol Metab. 2009 Aug;94(8):3025-30. doi: 10.1210/jc.2008-2680. Epub 2009 May 26.

PMID:
19470619
19.

Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

Diabetes Care. 2009 Jul;32(7):1170-6. doi: 10.2337/dc08-1874. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944.

20.

[Insulin allergies].

Sola-Gazagnes A.

Soins. 2007 Apr;(714 Suppl):S2, S4-5. French. No abstract available.

PMID:
17569273
21.

Type I and type IV allergy to the insulin analogue detemir.

Sola-Gazagnes A, Pecquet C, M'Bemba J, Larger E, Slama G.

Lancet. 2007 Feb 24;369(9562):637-8. No abstract available.

PMID:
17321300
22.

[Allergy to insulin in 2003].

Sola-Gazagnes A, Pecquet C.

Journ Annu Diabetol Hotel Dieu. 2004:161-79. Review. French. No abstract available.

PMID:
15259314
23.

Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin.

Sola-Gazagnes A, Pecquet C, Radermecker R, Piétri L, Elgrably F, Slama G, Sélam JL.

Diabetes Care. 2003 Oct;26(10):2961-2. No abstract available.

PMID:
14514615

Supplemental Content

Loading ...
Support Center